|
WO2021016256A2
|
|
Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors
|
|
WO2020210657A1
|
|
Solid forms of (e)-3-[2-(2-thienyl)vinyl]-1h-pyrazole
|
|
US2020071321A1
|
|
Methods and uses of compounds for treating disease
|
|
CA3073956A1
|
|
Vinylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors
|
|
US2018148438A1
|
|
Cytochrome P450 inhibitors and uses thereof
|
|
WO2017070536A1
|
|
Methods and agents for treating diseases
|
|
AU2015374231A1
|
|
Methods and agents for treating disease
|
|
AU2015301891A1
|
|
Cytochrome P450 inhibitors and uses thereof
|
|
US2015306078A1
|
|
Antifibrotic compounds and uses thereof
|
|
US2014309234A1
|
|
Small molecule anti-fibrotic compounds and uses thereof
|
|
WO2014093960A1
|
|
Compositions and methods for treating disease
|
|
WO2014040008A1
|
|
Relaxin-like peptides and uses thereof
|
|
US2016038490A1
|
|
Compositions and methods for treating dysproliferative diseases
|
|
WO2013177529A1
|
|
Relaxin-like compounds and uses thereof
|
|
AU2013211888A1
|
|
Antifibrotic compounds and uses thereof
|
|
US2014329871A1
|
|
Small molecule anti-fibrotic compounds and uses thereof
|
|
AU2011312333A1
|
|
Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
|
|
AU2011261586A1
|
|
Cytochrome P450 inhibitors and uses thereof
|
|
WO2011019400A2
|
|
Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity
|
|
WO2011016863A2
|
|
Methods and uses of cytochrome p450 inhibitors
|
